Mantini E L, Majors R K, Kennedy J R, Lebo G R
Ann Thorac Surg. 1977 Jul;24(1):62-7. doi: 10.1016/s0003-4975(10)64574-2.
This study, developed for the purpose of establishing an appropriate protocol for general follow-up of the paced patient, is based on clinical experience with patients derived from diverse specialties, geographical locations and protocol preferences. The analysis represents a four-year study of the transtelephonic follow-up of 1,705 implanted cardiac pacers, which represents 44,616 pacer-months of experience. There were 340 system malfunctions, 41% (141) due to battery exhaustion and 59% (199) due to other causes. Of all observed system failures 9.7% (33) occurred within 1 month of implantation, with the rate declining sharply thereafter until battery failures began to occur at approximately the twenty-fourth month. Only 10.9% (37) of all system failures were accompanied by clinical symptoms. Of the clinical failures, 62% (23) occurred in patients who were tested at intervals greater than 10 weeks. Our analysis indicates that testing should be performed weekly for the first month following lead manipulation. Thereafter, tests should be performed at 8- to 10-week intervals for the first 24 months of pacemaker life. During the third postimplant year tests should be conducted more frequently, depending on the energy source of the generator.
本研究旨在为心脏起搏器植入患者建立一套合适的常规随访方案,其依据的是来自不同专业、地理位置以及随访方案偏好的患者的临床经验。该分析是一项为期四年的针对1705例植入式心脏起搏器患者的电话随访研究,积累了44616个起搏器月的经验。共发生340次系统故障,其中41%(141次)是由于电池耗尽,59%(199次)是由其他原因导致。在所有观察到的系统故障中,9.7%(33次)发生在植入后的1个月内,此后发生率急剧下降,直到大约第24个月开始出现电池故障。所有系统故障中只有10.9%(37次)伴有临床症状。在有临床症状的故障中,62%(23次)发生在随访间隔大于10周的患者中。我们的分析表明,在导线操作后的第一个月应每周进行一次测试。此后,在起搏器使用的前24个月应每8至10周进行一次测试。在植入后的第三年,应根据起搏器的能源更频繁地进行测试。